As federal policymakers weigh potential changes to how biomedical research is funded and regulated in the United States, a ...

The application of computer-based tools and methodologies to simulate and model the human body in health and disease is known as computational biomedicine. It is a new, rapidly growing field ...

Magnet Biomedicine has entered a partnership and licence agreement with Eli Lilly to discover, develop and commercialise oncology molecular glue therapeutics. The partnership aims to utilise Magnet's ...

Biopharmaceuticals and biomedicine are two closely related fields within the broader domain of medicine and pharmaceuticals, both of which involve the study, development, and application of biological ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- H3 Biomedicine Inc. today announced that it has launched research and development operations in Cambridge, Massachusetts. H3 Biomedicine will undertake a ...

An interview with Dr Wei Min, describing his work involving the development of new chemical imaging techniques for studying small molecules, which led to him being awarded the 2019 Pittcon Achievement ...

The University of Pittsburgh launched the Trivedi Institute for Space and Global Biomedicine, a $25M research center led by ...

A biopharmaceutical, also known as a biologic medical product, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally ...

Produced by WIRED Brand Lab for CZI | Dr. Martin Chalfie and Dr. Akiko Iwasaki, two esteemed scientific researchers, explore the conversation around preprints through the lens of their own research, ...

Biomedicine's star is rising as a significant growth sector in the U.S. economy, providing evidence that advocates are using to encourage government investment. A report published today by the science ...

Note: Articles may be assigned to more than one subject area, as a result the sum of the subject research outputs may not equal the overall research outputs. Identify research insights to guide ...

One of China’s biggest pharmaceutical producers will team up with Shenzhen’s government to raise a 5-billion yuan (US$700 million) healthcare fund to invest in start-ups and innovations in cellular ...